Cell therapy specialist Chimeric Therapeutics (ASX: CHM) has entered into an agreement with The University of Texas MD Anderson Cancer Center to support the ADVENT-AML Phase 1B study, in which its off-the-shelf universal donor NK cell therapy CHM 0201 will be evaluated alongside the standard of care treatment for patients with newly-diagnosed acute myeloid leukaemia […]
The post Chimeric Therapeutics to supply CHM 0201 for cell study into treatments for acute myeloid leukaemia appeared first on Small Caps.
Global Securities Lenders specializes in custom liquidity solutions for those seeking to leverage concentrated market positions quickly, conveniently, and confidentially. We provide flexible terms and low interest rates specifically designed with your goals in mind. GSL recently announced our goal of working in Australia to provide securities lending to companies and high net worth individuals.
Securities-based lending, or a stock loan, is the practice of using market investments such as stocks, ETF’s, warrants, bonds, or real estate investment trusts as collateral for a loan. If you own free-trading, non-restricted stock on a major world exchange that trades at a minimum volume of $30,000 USD daily, you can qualify for a non-recourse, collateralized stock loan from one of our valued lenders in record time! Get an instant quote to see if you qualify.
Original Article: Read More
Original Source: Small Caps
Categories: Biotech & Pharma, CHM